These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2675751)

  • 21. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline.
    Hirt RA; Teinfalt M; Dederichs D; van den Hoven R
    J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):246-50. PubMed ID: 14567511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A; Fillastre JP; Humbert G
    Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
    Lacarelle B; Blin O; Audebert C; Auquier P; Karsenty H; Horriere F; Durand A
    Eur J Clin Pharmacol; 1994; 46(5):477-8. PubMed ID: 7957547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.
    Hasegawa T; Nadai M; Haghgoo S; Yamaki K; Takagi K; Nabeshima T
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2138-40. PubMed ID: 8540732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial effects of lomefloxacin in vitro.
    Chambers ST; Peddie BA; Robson RA; Begg EJ; Boswell DR
    J Antimicrob Chemother; 1991 Apr; 27(4):481-9. PubMed ID: 1856127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I pilot study of the effects of trovafloxacin (CP-99,219) on the pharmacokinetics of theophylline in healthy men.
    Dickens GR; Wermeling D; Vincent J
    J Clin Pharmacol; 1997 Mar; 37(3):248-52. PubMed ID: 9089427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lomefloxacin on the normal oral and intestinal microflora.
    Edlund C; Brismar B; Nord CE
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):35-9. PubMed ID: 2303064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theophylline and warfarin interaction studies with grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A; Blum B
    Clin Pharmacokinet; 1997; 33 Suppl 1():39-46. PubMed ID: 9433655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of new quinolone antimicrobial agents and macrolide antibiotics on the clearance of theophylline].
    Honma M
    Nihon Rinsho; 1996 Nov; 54(11):3125-9. PubMed ID: 8950966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog.
    Intorre L; Mengozzi G; Maccheroni M; Bertini S; Soldani G
    J Vet Pharmacol Ther; 1995 Oct; 18(5):352-6. PubMed ID: 8587153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
    Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D; Gaudin C; Benhamou JP
    Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
    Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose.
    Al-Turk WA; Shaheen OM; Othman S; Khalaf RM; Awidi AS
    Ther Drug Monit; 1988; 10(2):160-3. PubMed ID: 3164150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin.
    Butler T; Cartagenova M; Dunn D
    J Antimicrob Chemother; 1990 Apr; 25(4):629-34. PubMed ID: 2190972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of lomefloxacin in elderly patients with urinary tract infection following daily dosing with 400 mg.
    Cowling P; Rogers S; McMullin CM; White LO; Lovering AM; MacGowan AP; Reeves DS
    J Antimicrob Chemother; 1991 Jul; 28(1):101-7. PubMed ID: 1663107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.